LONGEFI
Company · Private

Biosplice Therapeutics

Targets splicing regulation to influence progenitor cell behaviour, with lead work in osteoarthritis.

Listing
Private
Ticker
—
Headquarters
San Diego, US
Founded
2008
Technology
Alternative splicing / stem cell modulation
Category

Longevity thesis

Modulating resident stem cell behaviour may repair tissue without cell transplantation.

Programmes

  • LorecivivintNDA submitted

    Knee osteoarthritis

Reference information for research context only. It is not a rating, a valuation or investment advice. Published developments appear in the News archive.